Viewing Study NCT04991532


Ignite Creation Date: 2025-12-24 @ 10:02 PM
Ignite Modification Date: 2025-12-25 @ 7:39 PM
Study NCT ID: NCT04991532
Status: UNKNOWN
Last Update Posted: 2021-08-05
First Post: 2021-08-03
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Dasatinib Down-regulates the Expression of PD-1 and Enhances Killing pH + Leukemia Stem Cells
Sponsor: Nanfang Hospital, Southern Medical University
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module